Evidence map›Paper›PMID 41634242›Full record

ArticleInterdisciplinary sciences, computational life sciences2026

IIC-DTI: A Contrastive Learning Enhanced Inter-Intra Molecular Fusing Framework for Drug-Target Interaction Prediction.

Fei Wang, Dacheng Ruan, Yang Zhang, Yue Chen, Xiujuan Lei, Fang-Xiang Wu, Yansen Su, Chunhou Zheng

Abstract read
PubMed Publisher
In one paragraph

Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fei WangKey Laboratory of Intelligent Computing and Signal Processing of Ministry of Education, School of Artificial Intelligence, Anhui University, Hefei, 230601, China.ORCID http://orcid.org/0000-0003-2157-9931
Dacheng RuanKey Laboratory of Intelligent Computing and Signal Processing of Ministry of Education, School of Artificial Intelligence, Anhui University, Hefei, 230601, China.
Yang ZhangKey Laboratory of Intelligent Computing and Signal Processing of Ministry of Education, School of Artificial Intelligence, Anhui University, Hefei, 230601, China.
Yue ChenKey Laboratory of Intelligent Computing and Signal Processing of Ministry of Education, School of Artificial Intelligence, Anhui University, Hefei, 230601, China.
Xiujuan LeiSchool of Artificial Intelligence and Computer Science, Shaanxi Normal University, Xi'an, 710119, China.
Fang-Xiang WuDepartment of Computer Science, University of Saskatchewan, Saskatoon, S7N 5A9, Canada. faw341@usask.ca.
Yansen SuKey Laboratory of Intelligent Computing and Signal Processing of Ministry of Education, School of Artificial Intelligence, Anhui University, Hefei, 230601, China. suyansen@ahu.edu.cn.
Chunhou ZhengKey Laboratory of Intelligent Computing and Signal Processing of Ministry of Education, School of Artificial Intelligence, Anhui University, Hefei, 230601, China. zhengch99@126.com.

Funding

National Natural Science Foundation of China 62302004Natural Science Foundation of Anhui Province 2308085QF223Natural Science Foundation of Anhui Province 62322301the State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia Fund SKL-HIDCA-2024-27the State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia Fund SKL-HIDCA-2024-AH2University Synergy Innovation Program of Anhui Province GXXT2021-039
6 · The paper itself

Abstract

purposePredicting drug-target interactions (DTIs) is a practical demand in drug development and drug repositioning. Therefore, developing accurate and efficient DTI prediction methods has significant application value. Current models focus on the features of either drugs or targets independently, and concatenate them together for downstream prediction. They ignore the hidden associations between drugs and targets, which may affect the implementation of DTIs.

methodsIn this work, we design a contrastive learning model to fuse intramolecular and intermolecular features of drugs and targets, named IIC-DTI. The intramolecular features focus on drug chemical structures and target amino acid sequences, which are generated separately. Meanwhile, the intermolecular features are focused on drug-target pairs, extracted by a multi-head cross-attention network. For the two embeddings of either a drug or a target in two views, a contrastive learning module is applied to update the embedding of one view by fusing information from the other view. Those novel embeddings are concatenated and fed into a 3-hidden layer neural network for predicting potential DTIs.

resultsMultiple comparative experiments show that our proposed model has better performance than nine state-of-the-art methods, including two pre-trained large language models, according to several evaluation metrics on four benchmark datasets. In case study, 16 out of 20 drug-target pairs were verified by literature evidence. Moreover, IIC-DTI identified related interactions of a given drug and target successfully. It indicates that IIC-DTI has the potential application to identify DTIs in realistic conditions.

Indexed as

Machine LearningNeural Networks, ComputerPharmaceutical PreparationsPharmaceutical PreparationsContrastive learningDrug–target interactionGraph convolutional networkMulti-head cross attention

Identifiers

PMID41634242

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.